caa a22 4500 469121459 CHVBK 20180323133140.0 cr unu---uuuuu 170328e19920201xx s 000 0 eng 10.1007/BF02246255 doi (NATIONALLICENCE)springer-10.1007/BF02246255 Patients at risk of suicide and overdose [Elektronische Daten] [G. Beaumont, W. Hetzel] Suicide is a complex and confusing subject. Although social factors may be important a clear relationship has been established between suicide and some medical conditions, notably depression, schizophrenia and alcohol dependence. Primary care physicians are in the "front line” as far as the recognition of suicidal risk is concerned. There is good evidence that many individuals who commit suicide have had recent contact with medical services. Those who have attempted suicide are at a much greater risk of subsequently completing the act than the general population. Poisoning by solids or liquids is a common method of committing suicide. Prescribed medication is often used. Antidepressants vary considerably in their toxicity in overdosage. Newer compounds, including moclobemide appear to be safer than older ones. There is some evidence that suicide rates can be influenced by changing the availability of lethal substances and methods. It is suggested the prescription of toxic antidepressants should be restricted or avoided in patients in whom the risk of suicide is high. Springer-Verlag, 1992 Suicide nationallicence Attempted suicide nationallicence Depression nationallicence Schizophrenia nationallicence Alcohol dependence nationallicence Recognition of suicide risk nationallicence Self poisoning nationallicence Toxicity of antidepressants in overdosage nationallicence Influencing suicide rates nationallicence Beaumont G. Hazel Grove, 11 Dorchester Road, SK7 5HE, Stockport, Cheshire, UK aut Hetzel W. Pharma Clinical Research Department, F. Hoffmann-La Roche Ltd, CH-4002, Basel, Switzerland aut Psychopharmacology Springer-Verlag 106(1992-02-01), S123-S126 0033-3158 106<S123 1992 106 213 https://doi.org/10.1007/BF02246255 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF02246255 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Beaumont G. Hazel Grove, 11 Dorchester Road, SK7 5HE, Stockport, Cheshire, UK aut NATIONALLICENCE 700 1- Hetzel W. Pharma Clinical Research Department, F. Hoffmann-La Roche Ltd, CH-4002, Basel, Switzerland aut NATIONALLICENCE 773 0- Psychopharmacology Springer-Verlag 106(1992-02-01), S123-S126 0033-3158 106<S123 1992 106 213 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer